Japan Tissue Engineering Co Ltd banner
J

Japan Tissue Engineering Co Ltd
TSE:7774

Watchlist Manager
Japan Tissue Engineering Co Ltd
TSE:7774
Watchlist
Price: 624 JPY -1.58% Market Closed
Market Cap: ¥25.3B

Japan Tissue Engineering Co Ltd
Investor Relations

Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ken-Ichiro Hata D.D.S., Ph.D.
President, CEO & Director
No Bio Available
Mr. Toshihiro Osuka
Senior Managing Executive Officer & Director
No Bio Available

Contacts

Address
AICHI-KEN
Gamagori-shi
6-209-1, Miyakita-dori
Contacts
+81533662020.0
www.jpte.co.jp